Cargando…
苯达莫司汀单药治疗复发/难治B细胞非霍奇金淋巴瘤：一项前瞻、多中心、单臂、Ⅱ期临床研究
OBJECTIVE: To evaluate the efficacy and safety of bendamustine monotherapy in Chinese patients with relapsed/refractory（R/R）B cell non-Hodgkin lymphoma（B-NHL）. METHODS: This prospective, multicenter, open label, single-arm, phase Ⅱ study investigated bendamustine's efficacy and safety in Chines...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808866/ https://www.ncbi.nlm.nih.gov/pubmed/36709185 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.11.009 |